About NeuroDex
NeuroDex is a company based in Natick (United States) founded in 2018 by Erez Eitan.. NeuroDex has raised $1.36 million across 6 funding rounds from investors including HHS and Conscious Capital. NeuroDex offers products and services including LuminEV kit and Neurodex. NeuroDex operates in a competitive market with competitors including Todos Medical, C₂N Diagnostics, ADmit Therapeutics, ALZpath and SYNAPS Dx, among others.
- Headquarter Natick, United States
- Founders Erez Eitan
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neurodex Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.36 M (USD)
in 6 rounds
-
Latest Funding Round
$2.15 M (USD), Grant
Sep 01, 2024
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NeuroDex
NeuroDex offers a comprehensive portfolio of products and services, including LuminEV kit and Neurodex. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Kit for isolating exosomes from plasma for disease detection.
Platform for identifying markers in synucleinopathies and dementia.
Unlock access to complete
Unlock access to complete
Funding Insights of NeuroDex
NeuroDex has successfully raised a total of $1.36M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $2.15 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $2.1M
-
First Round
First Round
(01 Sep 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Grant - NeuroDex | Valuation |
investors |
|
| Mar, 2023 | Amount | Seed - NeuroDex | Valuation |
investors |
|
| Sep, 2022 | Amount | Grant - NeuroDex | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NeuroDex
NeuroDex has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Conscious Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Diversified investment management is conducted by ICV in New York.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NeuroDex
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NeuroDex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neurodex Comparisons
Competitors of NeuroDex
NeuroDex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Todos Medical, C₂N Diagnostics, ADmit Therapeutics, ALZpath and SYNAPS Dx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Todos Medical is focused on developing diagnostic blood tests.
|
|
| domain | founded_year | HQ Location |
Diagnostics and therapies for Alzheimer's disease are developed.
|
|
| domain | founded_year | HQ Location |
Early Alzheimer's detection is facilitated through blood-based epigenetic diagnostics.
|
|
| domain | founded_year | HQ Location |
Diagnostic solutions for Alzheimer's disease are developed using blood-based biomarkers.
|
|
| domain | founded_year | HQ Location |
Developer of a diagnostic test to detect Alzheimer's disease
|
|
| domain | founded_year | HQ Location |
Developer of diagnostics test for detection of Alzheimer's disease
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neurodex
Frequently Asked Questions about NeuroDex
When was NeuroDex founded?
NeuroDex was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is NeuroDex located?
NeuroDex is headquartered in Natick, United States. It is registered at Natick, Massachusetts, United States.
Is NeuroDex a funded company?
NeuroDex is a funded company, having raised a total of $1.36M across 6 funding rounds to date. The company's 1st funding round was a Grant of $2.4M, raised on Sep 01, 2019.
What does NeuroDex do?
NeuroDex was founded in 2018 and is located in Natick, United States. Diagnostic tools for Alzheimers disease are produced, focusing on early detection, patient stratification, and disease monitoring. Proprietary neuron-derived exosome isolation technology is utilized, with applications extending to various neurological indications. Operations center on biotechnology development within the healthcare sector.
Who are the top competitors of NeuroDex?
NeuroDex's top competitors include ADmit Therapeutics, C₂N Diagnostics and Todos Medical.
What products or services does NeuroDex offer?
NeuroDex offers LuminEV kit and Neurodex.
Who are NeuroDex's investors?
NeuroDex has 2 investors. Key investors include HHS, and Conscious Capital.